Get the Stockscreener App
349.29
1.27%
-4.50
After Hours:
348.50
-0.79
-0.23%
Beone Medicines Ltd Adr stock is traded at $349.29, with a volume of 210.18K.
It is down -1.27% in the last 24 hours and up +9.64% over the past month.
Founded in 2010 in Beijing and having listed on the Hong Kong exchange in 2018, BeOne is a commercial-stage biotechnology company with global sales. It focuses on oncology therapeutics and differentiates itself from other companies with a contract research organization-free, or CRO-free strategy. BeOne runs global clinical trials with its own team. As of 2024, its core drug is Brukinsa, a small molecule drug for various blood cancers that makes up more than 60% of BeOne's revenue.
See More
Previous Close:
$353.79
Open:
$361.85
24h Volume:
210.18K
Relative Volume:
0.75
Market Cap:
$38.30B
Revenue:
$4.98B
Net Income/Loss:
$69.59M
P/E Ratio:
672.10
EPS:
0.5197
Net Cash Flow:
$525.67M
1W Performance:
-5.18%
1M Performance:
+9.64%
6M Performance:
+47.47%
1Y Performance:
+0.00%
1-Day Range:
$348.44
$364.97
1-Week Range:
$348.44
$385.22
52-Week Range:
$172.67
$385.22
Beone Medicines Ltd Adr Stock (ONC) Company Profile
Name
Beone Medicines Ltd Adr
Sector
Industry
Phone
41-616851900
Address
C/O BEONE MEDICINES I GMBH, BASEL
Compare ONC with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ONC
Beone Medicines Ltd Adr
|
349.29 | 39.15B | 4.98B | 69.59M | 525.67M | 0.5197 |
|
VRTX
Vertex Pharmaceuticals Inc
|
422.32 | 106.82B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
737.00 | 73.86B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
445.79 | 60.87B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
918.50 | 56.31B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
199.64 | 43.41B | 447.02M | -1.18B | -906.14M | -6.1812 |
Beone Medicines Ltd Adr Stock (ONC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Barclays | Overweight |
| Apr-07-25 | Initiated | RBC Capital Mkts | Outperform |
| Mar-03-25 | Upgrade | BofA Securities | Neutral → Buy |
| Dec-03-24 | Resumed | Morgan Stanley | Overweight |
| Sep-18-24 | Initiated | JMP Securities | Mkt Outperform |
| Feb-06-24 | Resumed | JP Morgan | Overweight |
| Sep-12-23 | Initiated | Macquarie | Outperform |
| Aug-17-23 | Initiated | Jefferies | Buy |
| Jul-17-23 | Initiated | Citigroup | Buy |
| Jun-30-23 | Downgrade | Bernstein | Outperform → Mkt Perform |
| Jan-12-23 | Initiated | Daiwa Securities | Buy |
| Oct-13-22 | Upgrade | Guggenheim | Neutral → Buy |
| Oct-13-22 | Upgrade | SVB Leerink | Mkt Perform → Outperform |
| Aug-09-22 | Resumed | JP Morgan | Overweight |
| Mar-17-22 | Downgrade | SVB Leerink | Outperform → Mkt Perform |
| Feb-07-22 | Initiated | Deutsche Bank | Buy |
| Oct-12-21 | Initiated | Bernstein | Outperform |
| Oct-06-21 | Upgrade | CLSA | Underperform → Buy |
| Mar-08-21 | Initiated | China Renaissance | Buy |
| Mar-01-21 | Downgrade | CLSA | Outperform → Underperform |
| Nov-09-20 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Nov-06-20 | Downgrade | Maxim Group | Buy → Hold |
| Nov-06-20 | Downgrade | Piper Sandler | Neutral → Underweight |
View All
Beone Medicines Ltd Adr Stock (ONC) Latest News
5,088,279 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Primecap Management Co. CA - MarketBeat
1,500 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Alteri Wealth LLC - MarketBeat
KBC Group NV Takes $2.18 Million Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Zymeworks, Jazz Pharmaceuticals Stocks Climb On Robust Gastroesophageal Trial Outcomes And Upcoming Regulatory Plans - Benzinga
Insider Selling: BeOne Medicines (NASDAQ:ONC) COO Sells $2,286,664.86 in Stock - Defense World
BeOne Medicines (NASDAQ:ONC) COO Xiaobin Wu Sells 10,000 Shares of Stock - MarketBeat
BeOne Medicines (NASDAQ:ONC) COO Xiaobin Wu Sells 6,009 Shares - MarketBeat
Fiera Capital Corp Invests $5.06 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Bank of Montreal Can Makes New $1.93 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Montag A & Associates Inc. Acquires New Stake in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Candriam S.C.A. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,839 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Vestmark Advisory Solutions Inc. - MarketBeat
M&G PLC Invests $41.19 Million in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Greenwoods Asset Management Hong Kong Ltd. Makes New $3.75 Million Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
4,740 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by Profund Advisors LLC - MarketBeat
ABC Arbitrage SA Takes $836,000 Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
ABC Arbitrage SA Takes $836,000 Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Penserra Capital Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Fox Run Management L.L.C. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines Ltd.Sponsored ADR (ONC) Q3 Earnings: How Key Metrics Compare to Wall Street Estimates - MSN
BeOne Medicines Ltd. – Sponsored ADR (NASDAQ:ONC) Receives Consensus Recommendation of “Moderate Buy” from Analysts - Defense World
Connor Clark & Lunn Investment Management Ltd. Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Y Intercept Hong Kong Ltd Makes New $564,000 Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
RBC Capital Adjusts Price Target on BeOne Medicines to $395 From $374, Maintains Outperform Rating - 富途牛牛
Envestnet Asset Management Inc. Acquires Shares of 62,220 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
5,362 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Purchased by EFG Asset Management North America Corp. - MarketBeat
ETFs Investing in BeOne Medicines Ltd. Sponsored ADR Stocks - TradingView
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Asset Management One Co. Ltd. Acquires New Shares in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Oppenheimer Asset Management Inc. Makes New Investment in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Allianz Asset Management GmbH Acquires Shares of 3,300 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
DekaBank Deutsche Girozentrale Purchases Shares of 13,600 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Yousif Capital Management LLC Invests $368,000 in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Sequoia Financial Advisors LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
Vanguard Personalized Indexing Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Janney Montgomery Scott LLC Takes $373,000 Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Callan Family Office LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
1,002 Shares in BeOne Medicines Ltd.Sponsored ADR $ONC Bought by IFP Advisors Inc - MarketBeat
Free cash flow per share of BeOne Medicines Ltd. Sponsored ADR – DUS:49BA - TradingView
Blue Trust Inc. Buys New Shares in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
BeOne Medicines (NASDAQ:ONC) Shares Gap DownHere's What Happened - MarketBeat
BeOne Medicines (ONC): Valuation Insight Following Positive Sonrotoclax Trial Results - Sahm
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd. – Sponsored ADR $ONC - Defense World
QRG Capital Management Inc. Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Net income before discontinued operations of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
Operating expenses (excl. COGS) of BeOne Medicines Ltd. Sponsored ADR – BOATS:ONC - TradingView
BeOne Medicines (NASDAQ:ONC) SVP Sells $3,739,118.40 in Stock - MarketBeat
Venturi Wealth Management LLC Takes Position in BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Mirae Asset Global Investments Co. Ltd. Buys Shares of 3,824 BeOne Medicines Ltd.Sponsored ADR $ONC - MarketBeat
Beone Medicines Ltd Adr Stock (ONC) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.93%
0.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):